Teva Pharmaceuticals has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.
In this site, learn more about Teva’s ongoing commitment and experience in neurological conditions like migraine.
Regeneron and Teva have also partnered to research chronic pain and further our understanding of the burden for adults living with chronic pain associated with OA.